Objective: This study was conducted to determine the frequency and characteristics of dengue patients presenting to Qazi Hussain Ahmed Medical Complex Nowshera. Dengue infection (DENV) disease is the most widely recognized mosquito-communicated viral contamination. DENV contamination can cause gentle dengue fever or extreme dengue hemorrhagic fever (DHF)/dengue stun condition (DSS). Drain and vascular spillage are two trademark side effects of DHF/DSS. Notwithstanding, because of the restricted comprehension of dengue pathogenesis, no acceptable treatments to treat nor immunization to forestall dengue disease are accessible, and the mortality of DHF/DSS is still high. DENV nonstructural protein 1 (NS1), which can be emitted in patients' sera, has been utilized as an early symptomatic marker for dengue contamination for a long time. In any case, the parts of NS1 in dengue-incited vascular spillage were depicted as of late. In this article, the pathogenic jobs of DENV NS1 in drain and vascular spillage are audited, and the chance of utilizing NS1 as a restorative objective and antibody up-and-comer is talked about. Material and Methods: This cross sectional observational study was conducted in Qazi Hussain Ahmed Medical Complex Nowshera from 5th July to 25th Sept 2017. A total of 72 cases were received for dengue serology. Relevant information’s were collected on a pre-designed questionnaire prepared in accordance with the objectives of the study. Dengue infection (DENV) is the most widely recognized mosquito-borne flavivirus and compromises individuals in jungle and subtropical zones. The World Health Organization assesses that more than 2.5 billion individuals addressing more than 40% of the total populace are in danger of dengue disease. Dengue infection diseases are regularly asymptomatic or cause influenza like disorder with fever and rash. In any case, a little extent of cases form into serious disease, which is named dengue hemorrhagic fever (DHF). DHF is portrayed by vascular spillage, thrombocytopenia, and coagulopathy. Vascular spillage brings about hemoconcentration and serous emissions, prompting circulatory breakdown, which further forms into hazardous dengue stun condition (DSS). An expected 390 million diseases happen every year around the world, and roughly 960,000 individuals with extreme dengue require hospitalization. Youngsters add to a huge extent of the serious illness cases. In 1958, DHF was accounted for to convey a case casualty rate (CFR) of 13.9% in Bangkok. Indeed, even with normalized determination and the board, the CFR stayed in the scope of 0.5-1.7% from 2000-2011 in the Philippines. Regardless of the high mortality of DHF/DSS, no encouraging viral-explicit medications or antibodies are accessible because of the restricted comprehension of the convoluted pathogenic instrument. Results: A total of 117 patients were referred from fever clinic and emergency OPD for dengue serology. 72(61.5%) were males and 45(38.5%) were females. 24(20.5%) cases were dengue positive. 14(12%) were NS1 positive, 8(8.8%) were IGM positive and 2 (1.7%) were IGM &IGG positive. We received patient in the range of 4 years to 60 years, Mean with SD was 27 +3 years. Out of 14 NS1 positive cases 8 were males and 6 females. 2 females were IGG positive. The spectrum of dengue in correlation with gender was significantly positive with p value .026. In two cases platelet at first visit were 58000/cmm3 that were both IGM&IGG positive. Out of 24 positive dengue cases two cases were also positive for plasmodium vivax (ring tropozoites). 6 cases were managed in hospital and discharged home with an average stay of 3 days and 4 cases referred to Lady Reading Hospital Peshawar for repeated platelet transfusion. Mortality was zero in our cases. Conclusion: The suspicion rate of the clinician for dengue from fever clinic was 1:7. The cause of poor rate can be contributed to the patient insist for doing the dengue test before they are screened for MP and FBC etc. NS1 was positive in 6 cases that shows that people reach the health care facility for screening well in time and patient are educated about the dengue. Females 50% positive cases were IGM and IGG positive that shows female receive the health care later than males as NSL1 positivity in female gender is less than males. The spectrum of dengue in correlation with gender was significantly positive with p value .025 that shows mosquito has some affinity for specific gender, or dengue virus has it for difference in gender or the inside immunity of the both gender is involved that causes different mode of presentation and activation of antibodies. Recommendation: Secondly high rate of false dengue infection by NS1-ICT should be discourages as low importance of NS1 protein in diagnosis and need of more sensitive test for proper diagnosis specially IgM and IgG or by ELISA or PCR-RNA techniques must be given importance before labeling a patient as Dengue positive.
A 31 year old female patient was evaluated with complaints of backache for last 3 months, dyspnoea on exertion, low grade fever, menorrhagia since last 1 month. On physical examination she was underweight with a BMI of 23kg/m2, no organomegaly, no obvious clinical sign. Investigations revealed Hb4gm/dl, reticulocyte proliferation index of 0.05, microcytic hypochromic anaemia with iron deficiency, serum albumin of 3.6 gm/dl, serum calcium 7.6 mg/dl, serum phosphorus 4.9mg/dl, normal LFT & KFT. Her hormone profile was normal, but iPTH was low at 6.10 pg/ml, DEXA scan showed Osteoporosis with Zscore of -5.084, Vitamin D levels were 113.5 ng/ml. Her urine albumin, bence jones protein initially was negative, MRI lumbar spine revealed disc herniation at multiple lumbosacral levels. A prelimnary diagnosis of Severe Iron deficiency anaemia with Primary Hypoparathyroidism with Osteoporosis was made .She was started on calcium supplementation, Inj Teripratide and haematinics. She returned after two months with worsening symptoms, no relief in backache. Investigations revealed Hb 3.6 gm/dl, S. Albumin 2.8 gm/dl, Globulins 9.5 gm/dl, S. Calcium of 8.2 mg/dl KFT was still normal. Bone marrow examination revealed plasma cells constituting 85-90% of haematopoetic cells. Serum electrophoresis revealed Monoclonal Gammopathy of 8.8 g/dl in gamma globulin region incresed seum IgG and Lambda light chain, serum beta 2 microglobulin of 6405ng/ml. The diagnosis of MULTIPLE MYELOMA was thus confirmed, was started on BCD regimen and she improved dramatically. Primary Hypoparathyroidism with Mutiple Myeloma is an unknown entity, in this case the paradoxical hypocalcaemia despite significant bone disease posed a diagnostic challenge, and lead to a delay in diagnosis. Ours is a unique case as no such case has previosly been reported. This could pave way for extensive research in the role of parathyroid in Myeloma pathogenesis. Hypercalcemia is a typical clinical issue with an expected pervasiveness of 15% among hospitalized patients. Different myeloma (MM) and essential hyperparathyroidism (PHPT) are among the most well-known reasons for hypercalcemia however concurrence of both pathologic cycles in a patient is an incredibly uncommon wonder. In this paper we have examined a patient giving this uncommon wonder. We have likewise given an exhaustive survey of the logical writing distributed on codiagnosis of MM and PHPT. Synopsis of distributed cases in Codiagnosis of PHPT and MM ought to be associated in cases with hard to-control hypercalcemia. The greater part of the instances of concurrent MM and PHPT have been seen in females (23 out of 29 announced cases). The most youthful patient with codiagnosis was a 45-year-old female and the most seasoned patient was a 92-year-old female. PHPT is more normal in females, though the inverse is valid for MM. Contrasts in occurrence of the two infections may clarify female dominance (MM less successive than PHPT). Introductory determination was exceptionally factor, eleven cases had essential analysis of hyperparathyroidism, ten had essential finding of MM and seven had both conclusion made at introduction. The kind of immunoglobulin chains of MM saw in all the cases was variable as six patients had light chain MM, remaining patients had a blend of weighty and light chain MM, one patient had nonsecretory sort of MM. All the patients had calcium ≥11 mg/dL at the hour of introduction. Larger part of patients had parathyroid adenoma as a reason for PHPT, scarcely any had boss cell hyperplasia, and none had parathyroid disease. Parathyroidectomy, blend of radiotherapy, and chemotherapy had been utilized for treatment of this concurrent condition with variable achievement. Rao et al. proposed that parathyroidectomy in patients with concurrent PHPT and MM serves three folds; first, it eliminates disarray about etiology of Vol.11 No.1 Short Communication Journal of Blood & Lymph 2021 hypercalcemia; second, it changes anticipation of myeloma; third, calcium can be utilized as a tumor marker in cases if there is a repeat of tumor. Thinking about age, our patient was not a contender for medical procedure, in such patient populace clinical option to parathyroidectomy is required. Ten out of 29-patients kicked the bucket inside 5 years after codiagnosis, and out of those ten, eight passed on inside one year.
Hereditary spherocytosis is a typical hemolytic problem described by an imperfection or lack in at least one of the proteins creating red platelet film. Therefore, red platelets have an unusual shape, higher metabolic necessities, and are rashly caught and obliterated in the spleen. Hereditary spherocytosis, including the exceptionally gentle or subclinical structures, is the most widely recognized reason for non-safe hemolytic pallor among individuals of Northern European parentage, with a commonness of roughly 1 out of 2000. Despite how extremely gentle types of the infection might be significantly more typical. Hereditary spherocytosis is acquired in a prevailing design in 75% of cases, though the excess are really latent cases and all over again changes. This audit reports current ideas on red cell layer construction and it will endeavor to explain sub-atomic deformities prompting spherocyte and their outcomes.
Significant strides have been made in flow cytometric cytogenetic and molecular techniques in diagnosing and prognosticating hematolymphoid malignancies as outlined in the recent WHO classification of tumours of hematopoietic and lymphoid tissues. Tissue biopsies acquire from patients with a suspected diagnosis of hematolymphoid malignancy should thus be handled in such a way that all necessary information may be gained for diagnostic and prognostic purposes. In general if the biopsy is acquired from a lymphoid site the tissue should be handled as a lymphomatous specimen until proven otherwise since these are irreplaceable specimens and they should be triaged appropriately. If the biopsy is from an extra nodal site and a diagnosis of a hematolymphoid malignancy is the primary concern such biopsies should also be handled as a lymphomatous specimen. When in doubt it is always better to process the sample as a lymphomatous specimen to ensure that all appropriate testing has been instituted for diagnostic and prognostic purposes.
Primary MALT non-Hodgkin’s lymphoma (NHL) of the uterus is an extremely rare entity. Both etiology and pathogenesis of these primary extranodal NHL lymphomas are unknown. Some researchers suppose a possible association between chronic inflammation, autoimmune diseases and lymphomas. We report a case of MALT uterine lymphoma of a 73-year-old woman. Postmenopausal vaginal bloody discharge was the leading symptom. Fractionated curettage was made and hystological analysis proven the MALT lymphoma diagnosis. Because of the low incidence of female genital tract lymphomas, there is no evidence-based consensus on its treatment. Eight cycles of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone; R-CHOP) chemoimmunotherapy was administered. The patient is disease-free after 20 months of therapy. R-CHOP is a good and tolerable treatment option in elderly patients. Further case reports and multicenter analysis can help to evaluate the long-term results of chemoimmunotherapy. Keywords: MALT uterine lymphoma, primary extranodal lymphoma, Rituximab-based therapy, rheumatoid arthritis linked lymphoma
Pharmacokinetics is the investigation of digestion of medications in organic liquids, tissues and excreta. The discoveries of ongoing improvements uncover that Multidrug Obstruction (MDR) adjusted the bioavailability of orally managed drugs through enlistment or restraint. Part of Multi-drug treatment: MDR is a term used to portray the marvel described by the capacity of medication safe tumors to display synchronous protection from various primarily and practically disconnected chemotherapeutic specialists. Various systems have been portrayed to clarify the wonder of MDR in mammalian cells. They have been extensively ordered into cell and non-cell components. Boundaries of pharmacokinetic inconstancy in malignancy patients:
The pharmaceutical industry plays a significant role in developing medications and vaccines to reduce the incidence of diseases, to treat diseases and enhance the quality of life of people. The industry’s main contribution is engaging in technological advancements through innovative research to meet the complex healthcare demands of populations. The global market for pharmaceuticals is expected to grow at an annual rate of 4.9% to $1.3 trillion by 2020. The U.S pharma market is expected to grow to $320 billion by 2020. The Japan market, the third largest pharmaceutical market, has a forecasted growth of 3% while the U.S has an expected growth rate of 5.6%.
Congestive vascular failure develops when ventricles unable to pump enough volume of blood to the body. Increase in the prevalence of cardiovascular diseases across regions is the major factors expected to drive the revenue growth of congestive vascular failure treatment globally. Lifestyle-related factors are expected to add to the growing disease incidence of CVDs. In addition, the growing number of obese patients is expected to bolster the congestive heart failure treatment market. The huge treatment demand for congestive vascular failure is expected to boost the treatment market. However, the availability of the generic drugs and lack of end-stage pipeline drugs and therapies for congestive vascular failure treatment is about to hinder the market.
The JAK-STAT pathway mediates signals that are involved in hematopoiesis. Aberrant JAK-STAT signaling has been identified in myeloproliferative neoplasm making the pathway a novel therapeutic target for myeloproliferative neoplasms through the application of JAK inhibitors. A major limitation to therapy with the current JAK inhibitors is a lack of selectivity which results in toxicity to patients. It is thought that increasing the selectivity of inhibitors will reduce toxicity observed with JAK inhibition therapy. System biology is a novel technology that holds great potentials for increasing the selectivity of JAK inhibitors. Its Application to drug designing can broaden the spectrum as well as repurpose the available JAK inhibitors for improved clinical outcome and possible cure for myeloproliferative neoplasms. This review presents an overview on the role of system biology in JAK inhibition therapy for myeloproliferative neoplasms.
